ANI Pharmaceuticals
ANIP
ANIP
158 hedge funds and large institutions have $320M invested in ANI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 24 closing their positions.
Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
62
Reduced
40
Closed
24
Calls
$2.71M
Puts
$18M
Net Calls
-$15.3M
Net Calls Change
-$12.1M
Top Buyers
1 |
1
BlackRock
New York
|
$56M |
2 |
2
First Manhattan
New York
|
$13.8M |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$8.79M |
4 |
KCM
4
Kennedy Capital Management
St Louis,
Missouri
|
$4.07M |
5 |
MP
5
Mangrove Partners
Greenwich,
Connecticut
|
$2.89M |